In addition, the in vivo deletion of Cdkn2a in mice lead to the development of lesions which recapitulate human angiosarcoma, however, only 30% of the mice displayed angiosarcomas within 100 days [24]. The gene discussed is CDKN2A; the disease is angiosarcoma.